From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.
Industrialized, small batch, and individual RNA therapeutics become practical with “in-a-box” manufacturing technology.
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company’s CRISPR-based ...
News-Medical.Net on MSN
CRISPR-based Cellgorithm technology ushers in a new era of cell programming
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback